ArticleAmerican heart journal plus : cardiology research and practice2022

Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies.

Arrigo F G Cicero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.